Table 2.

The results of the separate analyses of variance for initiation time (IT) and movement time (MT)

	IT		MT
	F (df)	p	F (df)	p
PD “off” vs. PD “on” medication
Medication state	0.63 (1,10)	0.4	0.57 (1,10)	0.5
Task	32.3 (1,10)	<0.001	0.32 (1,10)	0.6
Block	7.8 (3,30)	<0.001	1.9 (3,30)	0.1
Medication state × Task	0.69 (1,10)	0.4	0.14 (1,10)	0.7
Medication state × Block	0.31 (3,30)	0.81	0.36 (3,30)	0.8
Block × Task	0.91 (3,30)	0.4	0.03 (3,30)	1
Medication state × Task × Block	3.02 (3,30)	0.04	3.46 (3,30)	0.03
PD “off” medication vs. Healthy Participants
Group	0.98 (1,20)	0.3	6.0 (1,20)	0.02
Task	58 (1,20)	<0.001	1,0 (1,20)	0.3
Block	14.7 (3,60)	<0.001	1.6 (3,60)	0.2
Group × Task	0.48 (1,20)	0.5	(1,20)	0.9
Group × Block	2.0 (3,60)	0.1	1,1 (3,60)	0.4
Block × Task	1.2 (3,60)	0.3	1.1 (3,60)	0.4
Group × Task × Block	0.82 (3,60)	0.5	1.14 (3,60)	0.4
PD “on” medication vs. Healthy Participants
Group	1.6 (1,20)	0.2	2.7 (1,20)	0.1
Task	88.7 (1,20)	<0.001	0.4 (1,20)	0.5
Block	13.6 (3,60)	<0.001	1.2 (3,60)	0.3
Group × Task	0.15 (1,20)	0.7	0.23 (1,20)	0.6
Group × Block	0.75 (3,60)	0.5	0.15 (3,60)	0.9
Block × Task	3.73 (3,60)	0.02	1.6 (3,60)	0.2
Group × Task × Block	0.09 (3,60)	1	1.19 (3,60)	0.3

PD Parkinson’s disease

The significant effects are shown in bold type